Shilpa Bioscience secures European distribution partnership for recombinant human albumin
Indian biopharmaceutical company Shilpa Biocare has established a strategic commercial supply agreement with Finland’s Orion Corporation, positioning its innovative recom- binant human albumin for European market entry ahead of the BIO Boston conference.


